9:40am ET
Health and Healthcare
Johnson & Johnson Pharmaceutical, Domestic Sales Fuel Growth
Johnson & Johnson reported better-than-expected fiscal third-quarter financial results before the markets opened on Tuesday.
Chris Lange JNJ Coverage Page 53
Chris Lange 11:30am ET
Investing
Goldman Sachs and More Dow Earnings Kicking Off Tuesday
Earnings season is just kicking off for the third quarter with markets pushing all-time highs. Seven Dow stocks reporting this week, and nearly half of them are reporting on Tuesday.
10:25am ET
Investing
Goldman Sachs, GE, Verizon and More Dow Stocks Reporting This Week
24/7 Wall St. has put together a preview of GE, Verizon and other the Dow Jones Industrial Average companies scheduled to report their quarterly results this week.
4:01pm ET
Investing
Walmart, Johnson & Johnson Lift DJIA Wednesday
Walmart, Johnson & Johnson, McDonald's, and Visa pushed the DJIA higher on Wednesday.
9:00am ET
Investing
Top Analyst Upgrades and Downgrades: AbbVie, Amazon, Facebook, Johnson & Johnson, Schlumberger, Visa, Walmart and More
The top analyst upgrades, downgrades and other research calls from Wednesday include AbbVie, Gilead, Johnson & Johnson, Potash, Schlumberger, Visa and Walmart.
8:25am ET
Investing
Deutsche Bank Adds 5 Large Cap Leaders to Conviction List
These five new additions to Deutsche Bank’s Conviction List all make good sense for growth portfolios now.
9:05am ET
Investing
Top Analyst Upgrades and Downgrades: Ctrip, Goldman Sachs, Johnson & Johnson, Medtronic, Morgan Stanley, Yelp, Yum China and More
The top analyst upgrades, downgrades and other research calls from Monday include Ctrip.com, Goldman Sachs, Johnson & Johnson, Medtronic, Morgan Stanley, Yelp and Yum China.
10:55am ET
Health and Healthcare
Credit Suisse Identifies Top Mid-Large Cap Biotech and Pharma Stocks for Big Upside
U.S. pharmaceutical and biotech stocks may have considerable upside if Credit Suisse's views come to pass. But this part of the market has not come without controversy in the past year and…
8:20am ET
Health and Healthcare
Major Biotech, Pharma and FDA Catalysts Coming in October
24/7 Wall St. has collected several catalysts that are coming up in October for biotech and pharmaceutical companies.
9:10am ET
Investing
Top Analyst Upgrades and Downgrades: Albermarle, Blue Apron, Box, Dish Network, GM, Transocean, Under Armour and More
The top analyst upgrades, downgrades and other research calls from Monday include Albermarle, Blue Apron, Box, Dish Network, GM, Transocean and Under Armour.
4:01pm ET
Investing
Apple, Procter & Gamble Sink the DJIA Thursday
Apple, P&G, Johnson & Johnson, and Verizon led the DJIA lower on Thursday.
9:10am ET
Investing
Top Analyst Upgrades and Downgrades: Biogen, Electronic Arts, Gap, Intuit, J&J, 3M, Intercept, AutoZone and More
The top analyst upgrades, downgrades and other research calls from Wednesday include Biogen, Electronic Arts, Gap, Intuit, Johnson & Johnson, 3M, Intercept Pharmaceutical and AutoZone.
1:35pm ET
Health and Healthcare
Why Pfizer Is Pushing the Dow to All-Time Highs
Although the markets were mixed on Thursday, major drug manufacturers proved to be one of the more positive segments on the day.
7:15am ET
Health and Healthcare
Merrill Lynch Top Health Care Stock Picks for September: Focus on Large Cap Biotech
According to Merrill Lynch, the health care sector should act as a good hedge against volatility. Even biotech was shown to offer growth at a reasonable price.
8:50am ET
Health and Healthcare
Achillion Pharma Slides After Hep C Deal Is Terminated
Achillion Pharmaceuticals saw its shares slump early on Monday after the firm announced that its hepatitis C license and collaboration agreement with Janssen had been terminated.
Chris Lange